Everything You Should Know - Breaking News on Paxil and the Harm it Causes
If your child has birth defects caused by Paxil, you may be able to file a Paxil lawsuit and get compensation for your child's pain and suffering. In this section, keep up to date with the latest breaking news and warnings on Paxil. To see if you may qualify for a Paxil lawsuit, fill out this simple form today.
Antidepressant Linked to Violent Behavior
September 12, 2006 (Forbes.com)
Study participants who took the antidepressant Paxil (paroxetine) were twice
as likely to have violent episodes as those who took a placebo, a British study
concludes.
The GlaxoSmithKline drug is among a class of antidepressants
called selective serotonin reuptake inhibitors (SSRIs), which prior research has
linked to an increased risk of suicidal thoughts and behaviors.
The new
study from researchers at Cardiff University and the Cochrane Centre is
published on the Public Library of Science (PLoS) - Medicine Web site. The
scientists studied data provided by several sources, including Glaxo, according
to Britain's The Guardian newspaper.
"The new issues highlighted by these
cases need urgent examination in all countries where antidepressants are widely
used," the researchers wrote.
Early results suggest Paxil birth defect risk
December 8, 2005 (reuters.com)
Preliminary findings from two studies showed women who took Paxil during the first three months of pregnancy were about 1.5 to 2 times as likely to have a baby with a heart defect as women who took other antidepressants, or women in the general population, the FDA said.
Paxil linked to birth defects
September 30, 2005 (mydna.com)
GlaxoSmithKline Inc. (GSK) has issued a warning to physicians concerning their anti-depression drug Paxil, as it may put women at an added risk for birth defects when compared to similar mental health medications.
Glaxo adds birth defect caution to Paxil label
September 27, 2005 (reuters.com)
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) (GSK.N: Quote, Profile, Research) is alerting physicians about a study suggesting the company's antidepressant Paxil may be more likely to be linked to birth defects than similar drugs, U.S. regulators said on Tuesday.
Paxil's Birth Defects Warning Strengthened
September 27, 2005 (scoopt.com)
The FDA and the drug company GlaxoSmithKline are alerting doctors about a new study on major birth defects seen in babies born to women who took the antidepressant Paxil during the first trimester of pregnancy. "Healthcare professionals are advised to carefully weigh the potential risks and benefits of using [Paxil] in women during pregnancy and to discuss these findings as well as treatment alternatives with their patients," the FDA says in a news release.see also:
Inactive Shipment
News & Warnings--Glaxo May Have Shipped Inactive Paxil CR PillsWhat you need to know: Glaxo May Have Shipped Inactive Paxil CR Pills
Letter to Healthcare Professionals
Paxil maker's letter to Healthcare Professionals on Paxil & Pregnancy Letter to healthcare professionals from Paxil-maker on new precautions
News & Warnings
The latest News and warnings on the damage-inducing drug PaxilAre you up to date? Read the latest Paxil news all users need to know
